| Year |
Citation |
Score |
| 2020 |
Futatsugi K, Smith AC, Tu M, Raymer B, Ahn K, Coffey SB, Dowling MS, Fernando DP, Gutierrez JA, Huard K, Jasti J, Kalgutkar AS, Knafels JD, Pandit J, Parris KD, ... ... Pfefferkorn JA, et al. Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of Fructose. Journal of Medicinal Chemistry. PMID 32910646 DOI: 10.1021/Acs.Jmedchem.0C00944 |
0.357 |
|
| 2020 |
Huard K, Smith AC, Cappon GD, Dow RL, Edmonds DJ, El-Kattan A, Esler WP, Fernando DP, Griffith DA, Kalgutkar AS, Ross T, Bagley SW, Beebe D, Bi YA, Cabral S, ... ... Pfefferkorn JA, et al. Optimizing the Benefit/Risk of Acetyl-CoA Carboxylase (ACC) Inhibitors Through Liver Targeting. Journal of Medicinal Chemistry. PMID 32809824 DOI: 10.1021/Acs.Jmedchem.0C00640 |
0.35 |
|
| 2019 |
Esler WP, Tesz GJ, Hellerstein MK, Beysen C, Sivamani R, Turner SM, Watkins SM, Amor PA, Carvajal-Gonzalez S, Geoly FJ, Biddle KE, Purkal JJ, Fitch M, Buckeridge C, Silvia AM, ... ... Pfefferkorn JA, et al. Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition. Science Translational Medicine. 11. PMID 31092695 DOI: 10.1126/Scitranslmed.Aau8465 |
0.302 |
|
| 2017 |
Huard K, Ahn K, Amor PA, Beebe DA, Borzilleri KA, Chrunyk BA, Coffey SB, Cong Y, Conn EL, Culp JS, Dowling MS, Gorgoglione MF, Gutierrez JA, Knafels JD, Lachapelle EA, ... ... Pfefferkorn JA, et al. Discovery of Fragment-Derived Small Molecules for In Vivo Inhibition of Ketohexokinase (KHK). Journal of Medicinal Chemistry. PMID 28853885 DOI: 10.1021/Acs.Jmedchem.7B00947 |
0.393 |
|
| 2016 |
Ahn K, Brown MF, Boehm M, Calloway J, Che Y, Chen JM, Fennell K, Geoghegan KF, Gilbert AM, Gutierrez JA, Kalgutkar AS, Lanba A, Limberakis C, Magee TV, O'Doherty I, ... ... Pfefferkorn JA, et al. Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism. Acs Chemical Biology. PMID 27391855 DOI: 10.1021/Acschembio.6B00266 |
0.324 |
|
| 2015 |
Huard K, Brown J, Jones JC, Cabral S, Futatsugi K, Gorgoglione M, Lanba A, Vera NB, Zhu Y, Yan Q, Zhou Y, Vernochet C, Riccardi K, Wolford A, Pirman D, ... ... Pfefferkorn JA, et al. Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). Scientific Reports. 5: 17391. PMID 26620127 DOI: 10.1038/Srep17391 |
0.32 |
|
| 2015 |
Futatsugi K, Kung DW, Orr ST, Cabral S, Hepworth D, Aspnes G, Bader S, Bian J, Boehm M, Carpino PA, Coffey SB, Dowling MS, Herr M, Jiao W, Lavergne SY, ... ... Pfefferkorn JA, et al. Discovery and Optimization of Imidazopyridine-Based Inhibitors of Diacylglycerol Acyltransferase 2 (DGAT2). Journal of Medicinal Chemistry. PMID 26349027 DOI: 10.1021/Acs.Jmedchem.5B01006 |
0.377 |
|
| 2015 |
Sharma R, Litchfield J, Bergman A, Atkinson K, Kazierad D, Gustavson SM, Di L, Pfefferkorn JA, Kalgutkar AS. Comparison of the circulating metabolite profile of PF-04991532, a hepatoselective glucokinase activator, across preclinical species and humans: potential implications in metabolites in safety testing assessment. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 190-8. PMID 25384899 DOI: 10.1124/Dmd.114.061218 |
0.309 |
|
| 2014 |
Lee EC, Tu M, Stevens BD, Bian J, Aspnes G, Perreault C, Sammons MF, Wright SW, Litchfield J, Kalgutkar AS, Sharma R, Didiuk MT, Ebner DC, Filipski KJ, Brown J, ... ... Pfefferkorn JA, et al. Identification of a novel conformationally constrained glucagon receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 24: 839-44. PMID 24418771 DOI: 10.1016/J.Bmcl.2013.12.090 |
0.326 |
|
| 2014 |
Borzilleri KA, Pfefferkorn JA, Guzman-Perez A, Liu S, Qiu X, Chrunyk BA, Song X, Tu M, Filipski KJ, Aiello R, Derksen DR, Bourbonais FJ, Landro J, Bourassa P, D'Aquila T, et al. Optimizing glucokinase activator binding kinetics to lower in vivo hypoglycemia risk Medchemcomm. 5: 802-804. DOI: 10.1039/C4Md00027G |
0.314 |
|
| 2013 |
Stevens BD, Litchfield J, Pfefferkorn JA, Atkinson K, Perreault C, Amor P, Bahnck K, Berliner MA, Calloway J, Carlo A, Derksen DR, Filipski KJ, Gumkowski M, Jassal C, MacDougall M, et al. Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia. Bioorganic & Medicinal Chemistry Letters. 23: 6588-92. PMID 24239482 DOI: 10.1016/J.Bmcl.2013.10.057 |
0.315 |
|
| 2013 |
Filipski KJ, Guzman-Perez A, Bian J, Perreault C, Aspnes GE, Didiuk MT, Dow RL, Hank RF, Jones CS, Maguire RJ, Tu M, Zeng D, Liu S, Knafels JD, Litchfield J, ... ... Pfefferkorn JA, et al. Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motif. Bioorganic & Medicinal Chemistry Letters. 23: 4571-8. PMID 23831135 DOI: 10.1016/J.Bmcl.2013.06.036 |
0.365 |
|
| 2013 |
Tu M, Mathiowetz AM, Pfefferkorn JA, Cameron KO, Dow RL, Litchfield J, Di L, Feng B, Liras S. Medicinal chemistry design principles for liver targeting through OATP transporters. Current Topics in Medicinal Chemistry. 13: 857-66. PMID 23578029 DOI: 10.2174/1568026611313070008 |
0.319 |
|
| 2013 |
Guzman-Perez A, Pfefferkorn JA, Lee EC, Stevens BD, Aspnes GE, Bian J, Didiuk MT, Filipski KJ, Moore D, Perreault C, Sammons MF, Tu M, Brown J, Atkinson K, Litchfield J, et al. The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry Letters. 23: 3051-8. PMID 23562063 DOI: 10.1016/J.Bmcl.2013.03.014 |
0.33 |
|
| 2012 |
Tu M, Pfefferkorn JA, Guzman-Perez A, Filipski KJ. Building structure-activity insights through patent mining. Pharmaceutical Patent Analyst. 1: 545-54. PMID 24236924 DOI: 10.4155/Ppa.12.60 |
0.326 |
|
| 2012 |
Pfefferkorn JA, Tu M, Filipski KJ, Guzman-Perez A, Bian J, Aspnes GE, Sammons MF, Song W, Li JC, Jones CS, Patel L, Rasmusson T, Zeng D, Karki K, Hamilton M, et al. The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry Letters. 22: 7100-5. PMID 23089526 DOI: 10.1016/J.Bmcl.2012.09.082 |
0.34 |
|
| 2012 |
Tu M, Rai BK, Mathiowetz AM, Didiuk M, Pfefferkorn JA, Guzman-Perez A, Benbow J, Guimarães CR, Mente S, Hayward MM, Liras S. Exploring aromatic chemical space with NEAT: novel and electronically equivalent aromatic template. Journal of Chemical Information and Modeling. 52: 1114-23. PMID 22486394 DOI: 10.1021/Ci300031S |
0.305 |
|
| 2012 |
Pfefferkorn JA, Guzman-Perez A, Litchfield J, Aiello R, Treadway JL, Pettersen J, Minich ML, Filipski KJ, Jones CS, Tu M, Aspnes G, Risley H, Bian J, Stevens BD, Bourassa P, et al. Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. Journal of Medicinal Chemistry. 55: 1318-33. PMID 22196621 DOI: 10.1021/Jm2014887 |
0.317 |
|
| 2012 |
Filipski KJ, Bian J, Ebner DC, Lee EC, Li JC, Sammons MF, Wright SW, Stevens BD, Didiuk MT, Tu M, Perreault C, Brown J, Atkinson K, Tan B, Salatto CT, ... ... Pfefferkorn JA, et al. A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity. Bioorganic & Medicinal Chemistry Letters. 22: 415-20. PMID 22119466 DOI: 10.1016/J.Bmcl.2011.10.113 |
0.317 |
|
| 2012 |
Bourbonais FJ, Chen J, Huang C, Zhang Y, Pfefferkorn JA, Landro JA. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis. The Biochemical Journal. 441: 881-7. PMID 22044397 DOI: 10.1042/Bj20110721 |
0.318 |
|
| 2011 |
Pfefferkorn JA, Litchfield J, Hutchings R, Cheng XM, Larsen SD, Auerbach B, Bush MR, Lee C, Erasga N, Bowles DM, Boyles DC, Lu G, Sekerke C, Askew V, Hanselman JC, et al. Discovery of novel hepatoselective HMG-CoA reductase inhibitors for treating hypercholesterolemia: a bench-to-bedside case study on tissue selective drug distribution. Bioorganic & Medicinal Chemistry Letters. 21: 2725-31. PMID 21183342 DOI: 10.1016/J.Bmcl.2010.11.103 |
0.309 |
|
| 2011 |
Pfefferkorn JA, Guzman-Perez A, Oates PJ, Litchfield J, Aspnes G, Basak A, Benbow J, Berliner MA, Bian J, Choi C, Freeman-Cook K, Corbett JW, Didiuk M, Dunetz JR, Filipski KJ, et al. Designing glucokinase activators with reduced hypoglycemia risk: Discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4- yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus Medchemcomm. 2: 828-839. DOI: 10.1039/C1Md00116G |
0.302 |
|
| 2011 |
Bowles DM, Boyles DC, Choi C, Pfefferkorn JA, Schuyler S, Hessler EJ. Development of an early enabling synthesis for PF-03052334-02: A novel hepatoselective HMG-CoA reductase inhibitor Organic Process Research and Development. 15: 148-157. DOI: 10.1021/Op100268E |
0.408 |
|
| 2009 |
Pfefferkorn JA, Lou J, Minich ML, Filipski KJ, He M, Zhou R, Ahmed S, Benbow J, Perez AG, Tu M, Litchfield J, Sharma R, Metzler K, Bourbonais F, Huang C, et al. Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle. Bioorganic & Medicinal Chemistry Letters. 19: 3247-52. PMID 19435665 DOI: 10.1016/J.Bmcl.2009.04.107 |
0.34 |
|
| 2009 |
Minich ML, Watson ID, Filipski KJ, Pfefferkorn JA. Novel and efficient synthesis of 4-sulfonyl-2-pyridones Tetrahedron Letters. 50: 2094-2096. DOI: 10.1016/J.Tetlet.2009.02.120 |
0.413 |
|
| 2008 |
Sarver RW, Bills E, Bolton G, Bratton LD, Caspers NL, Dunbar JB, Harris MS, Hutchings RH, Kennedy RM, Larsen SD, Pavlovsky A, Pfefferkorn JA, Bainbridge G. Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Journal of Medicinal Chemistry. 51: 3804-13. PMID 18540668 DOI: 10.1021/Jm7015057 |
0.33 |
|
| 2008 |
Pfefferkorn JA, Choi C, Larsen SD, Auerbach B, Hutchings R, Park W, Askew V, Dillon L, Hanselman JC, Lin Z, Lu GH, Robertson A, Sekerke C, Harris MS, Pavlovsky A, et al. Substituted pyrazoles as hepatoselective HMG-CoA reductase inhibitors: discovery of (3R,5R)-7-[2-(4-fluoro-phenyl)-4-isopropyl-5-(4-methyl-benzylcarbamoyl)-2H-pyrazol-3-yl]-3,5-dihydroxyheptanoic acid (PF-3052334) as a candidate for the treatment of hypercholesterolemia. Journal of Medicinal Chemistry. 51: 31-45. PMID 18072721 DOI: 10.1021/Jm070849R |
0.331 |
|
| 2008 |
Pfefferkorn JA, Larsen SD, Van Huis C, Sorenson R, Barton T, Winters T, Auerbach B, Wu C, Wolfram TJ, Cai H, Welch K, Esmaiel N, Davis J, Bousley R, Olsen K, et al. Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption. Bioorganic & Medicinal Chemistry Letters. 18: 546-53. PMID 18063367 DOI: 10.1016/J.Bmcl.2007.11.083 |
0.313 |
|
| 2008 |
Pfefferkorn JA, Choi C. Convenient synthesis of 1,1′-H-spiro[indoline-3,3′-piperidine] Tetrahedron Letters. 49: 4372-4373. DOI: 10.1016/J.Tetlet.2008.05.024 |
0.346 |
|
| 2007 |
Larsen SD, Poel TJ, Filipski KJ, Kohrt JT, Pfefferkorn JA, Sorenson RJ, Tait BD, Askew V, Dillon L, Hanselman JC, Lu GH, Robertson A, Sekerke C, Kowala MC, Auerbach BJ. Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-design. Bioorganic & Medicinal Chemistry Letters. 17: 5567-72. PMID 17764936 DOI: 10.1016/J.Bmcl.2007.08.004 |
0.414 |
|
| 2007 |
Pfefferkorn JA, Song Y, Sun KL, Miller SR, Trivedi BK, Choi C, Sorenson RJ, Bratton LD, Unangst PC, Larsen SD, Poel TJ, Cheng XM, Lee C, Erasga N, Auerbach B, et al. Design and synthesis of hepatoselective, pyrrole-based HMG-CoA reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 4538-44. PMID 17574412 DOI: 10.1016/J.Bmcl.2007.05.096 |
0.385 |
|
| 2007 |
Pfefferkorn JA, Choi C, Song Y, Trivedi BK, Larsen SD, Askew V, Dillon L, Hanselman JC, Lin Z, Lu G, Robertson A, Sekerke C, Auerbach B, Pavlovsky A, Harris MS, et al. Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 4531-7. PMID 17574411 DOI: 10.1016/J.Bmcl.2007.05.097 |
0.396 |
|
| 2007 |
Bratton LD, Auerbach B, Choi C, Dillon L, Hanselman JC, Larsen SD, Lu G, Olsen K, Pfefferkorn JA, Robertson A, Sekerke C, Trivedi BK, Unangst PC. Discovery of pyrrole-based hepatoselective ligands as potent inhibitors of HMG-CoA reductase. Bioorganic & Medicinal Chemistry. 15: 5576-89. PMID 17560788 DOI: 10.1016/J.Bmc.2007.05.031 |
0.407 |
|
| 2007 |
Pfefferkorn JA, Bowles DM, Kissel W, Boyles DC, Choi C, Larsen SD, Song Y, Sun KL, Miller SR, Trivedi BK. Development of a practical synthesis of novel, pyrrole-based HMG-CoA reductase inhibitors Tetrahedron. 63: 8124-8134. DOI: 10.1016/J.Tet.2007.06.005 |
0.44 |
|
| 2005 |
Pfefferkorn JA, Greene ML, Nugent RA, Gross RJ, Mitchell MA, Finzel BC, Harris MS, Wells PA, Shelly JA, Anstadt RA, Kilkuskie RE, Kopta LA, Schwende FJ. Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid. Bioorganic & Medicinal Chemistry Letters. 15: 2481-6. PMID 15863301 DOI: 10.1016/J.Bmcl.2005.03.066 |
0.324 |
|
| 2003 |
Nicolaou KC, Evans RM, Roecker AJ, Hughes R, Downes M, Pfefferkorn JA. Discovery and optimization of non-steroidal FXR agonists from natural product-like libraries. Organic & Biomolecular Chemistry. 1: 908-20. PMID 12929628 DOI: 10.1039/B300525A |
0.779 |
|
| 2003 |
Nicolaou KC, Roecker AJ, Hughes R, van Summeren R, Pfefferkorn JA, Winssinger N. Novel strategies for the solid phase synthesis of substituted indolines and indoles. Bioorganic & Medicinal Chemistry. 11: 465-76. PMID 12517442 DOI: 10.1016/S0968-0896(02)00386-3 |
0.768 |
|
| 2002 |
Nicholas GM, Eckman LL, Ray S, Hughes RO, Pfefferkorn JA, Barluenga S, Nicolaou KC, Bewley CA. Bromotyrosine-derived natural and synthetic products as inhibitors of mycothiol-S-conjugate amidase. Bioorganic & Medicinal Chemistry Letters. 12: 2487-90. PMID 12161164 DOI: 10.1016/S0960-894X(02)00385-2 |
0.746 |
|
| 2001 |
Nicolaou KC, Roecker AJ, Barluenga S, Pfefferkorn JA, Cao GQ. Discovery of novel antibacterial agents active against methicillin-resistant Staphylococcus aureus from combinatorial benzopyran libraries. Chembiochem : a European Journal of Chemical Biology. 2: 460-5. PMID 11828478 DOI: 10.1002/1439-7633(20010601)2:6<460::Aid-Cbic460>3.0.Co;2-2 |
0.751 |
|
| 2001 |
Nicolaou KC, Pfefferkorn JA. Solid phase synthesis of complex natural products and libraries thereof. Biopolymers. 60: 171-93. PMID 11774224 DOI: 10.1002/1097-0282(2001)60:3<171::Aid-Bip10030>3.0.Co;2-M |
0.562 |
|
| 2001 |
Nicolaou KC, Hughes R, Pfefferkorn JA, Barluenga S. Optimization and mechanistic studies of psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA). Chemistry (Weinheim An Der Bergstrasse, Germany). 7: 4296-310. PMID 11686610 DOI: 10.1002/1521-3765(20011001)7:19<4296::Aid-Chem4296>3.0.Co;2-2 |
0.769 |
|
| 2001 |
Nicolaou KC, Hughes R, Pfefferkorn JA, Barluenga S, Roecker AJ. Combinatorial synthesis through disulfide exchange: discovery of potent psammaplin A type antibacterial agents active against methicillin-resistant Staphylococcus aureus (MRSA). Chemistry (Weinheim An Der Bergstrasse, Germany). 7: 4280-95. PMID 11686609 DOI: 10.1002/1521-3765(20011001)7:19<4280::Aid-Chem4280>3.0.Co;2-3 |
0.771 |
|
| 2000 |
Nicolaou KC, Pfefferkorn JA, Schuler F, Roecker AJ, Cao GQ, Casida JE. Combinatorial synthesis of novel and potent inhibitors of NADH:ubiquinone oxidoreductase Chemistry and Biology. 7: 979-992. PMID 11137820 DOI: 10.1016/S1074-5521(00)00047-8 |
0.712 |
|
| 2000 |
Nicolaou KC, Snyder SA, Bigot A, Pfefferkorn JA. Solution and Solid-Phase Synthesis of Functionalized 3-Arylbenzofurans by a Novel Cyclofragmentation - Release Pathway Financial support for this work was provided by The Skaggs Institute for Chemical Biology, the National Institutes of Health (USA), doctoral fellowships from the National Science Foundation (S.A.S.) and the Department of Defense (J.A.P.), and grants from Abbott, Amgen, Boehringer - Ingelheim, Glaxo, Hoffmann - La Roche, DuPont, Merck, Novartis, Pfizer, and Schering Plough. Angewandte Chemie (International Ed. in English). 39: 1093-1096. PMID 10760931 DOI: 10.1002/(Sici)1521-3773(20000317)39:6<1093::Aid-Anie1093>3.0.Co;2-S |
0.576 |
|
| 2000 |
Nicolaou KC, Cao GQ, Pfefferkorn JA. Selenium-Based Solid-Phase Synthesis of Benzopyrans II: Applications to Combinatorial Synthesis of Medicinally Relevant Small Organic Molecules. Angewandte Chemie (International Ed. in English). 39: 739-743. PMID 10760853 DOI: 10.1002/(Sici)1521-3773(20000218)39:4<739::Aid-Anie739>3.0.Co;2-Z |
0.506 |
|
| 2000 |
Nicolaou KC, Pfefferkorn JA, Cao GQ. Selenium-Based Solid-Phase Synthesis of Benzopyrans I: Applications to Combinatorial Synthesis of Natural Products. Angewandte Chemie (International Ed. in English). 39: 734-739. PMID 10760852 DOI: 10.1002/(Sici)1521-3757(20000218)112:4<750::Aid-Ange750>3.0.Co;2-J |
0.544 |
|
| 2000 |
Nicolaou KC, Roecker AJ, Pfefferkorn JA, Cao GQ. A novel strategy for the solid-phase synthesis of substituted indolines [12] Journal of the American Chemical Society. 122: 2966-2967. DOI: 10.1021/Ja994373F |
0.717 |
|
| 2000 |
Nicolaou KC, Pfefferkorn JA, Barluenga S, Mitchell HJ, Roecker AJ, Cao GQ. Natural product-like combinatorial libraries based on privileged structures. 3. The 'libraries from libraries' principle for diversity enhancement of benzopyran libraries Journal of the American Chemical Society. 122: 9968-9976. DOI: 10.1021/Ja0020355 |
0.772 |
|
| 2000 |
Nicolaou KC, Pfefferkorn JA, Mitchell HJ, Roecker AJ, Barluenga S, Cao GQ, Affleck RL, Lillig JE. Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using NanoKans and optical encoding Journal of the American Chemical Society. 122: 9954-9967. DOI: 10.1021/Ja002034C |
0.776 |
|
| 2000 |
Nicolaou KC, Pfefferkorn JA, Roecker AJ, Cao GQ, Barluenga S, Mitchell HJ. Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans Journal of the American Chemical Society. 122: 9939-9953. DOI: 10.1021/Ja002033K |
0.79 |
|
| 1999 |
Nicolaou KC, Pfefferkorn JA, Cao GQ, Kim S, Kessabi J. A facile method for the solution and solid-phase synthesis of substituted [3.3.1] bicycles. Organic Letters. 1: 807-10. PMID 10823208 DOI: 10.1021/Ol990791D |
0.487 |
|
| 1999 |
Nicolaou KC, Pfefferkorn J, Xu J, Winssinger N, Ohshima T, Kim S, Hosokawa S, Vourloumis D, van Delft F, Li T. Total synthesis and chemical biology of the sarcodictyins. Chemical & Pharmaceutical Bulletin. 47: 1199-213. PMID 10517002 DOI: 10.1248/Cpb.47.1199 |
0.668 |
|
| 1999 |
Nicolaou KC, Pfefferkorn JA, Kim S, Wei HX. Synthesis of the fully functionalized bicyclic core of garsubellin A Journal of the American Chemical Society. 121: 4724-4725. DOI: 10.1021/Ja9905445 |
0.457 |
|
| 1999 |
Nicolaou KC, Winssinger N, Vourloumis D, Ohshima T, Kim S, Pfefferkorn J, Xu JY, Li T, Hosokawa S. Total synthesis of sarcodictyins A and B: Solid- and solution-phase synthesis and biological evaluation of combinatorial sarcodictyin libraries Chemtracts. 12: 1006-1012. DOI: 10.1021/Ja981062G |
0.632 |
|
| 1998 |
Nicolaou KC, Kim S, Pfefferkorn J, Xu J, Ohshima T, Hosokawa S, Vourloumis D, Li T. Synthesis and Biological Activity of Sarcodictyins. Angewandte Chemie (International Ed. in English). 37: 1418-1421. PMID 29710898 DOI: 10.1002/(Sici)1521-3773(19980605)37:10<1418::Aid-Anie1418>3.0.Co;2-5 |
0.532 |
|
| 1998 |
Nicolaou KC, Winssinger N, Vourloumis D, Ohshima T, Kim S, Pfefferkorn J, Xu JY, Li T. Solid and solution phase synthesis and biological evaluation of combinatorial sarcodictyin libraries Journal of the American Chemical Society. 120: 10814-10826. DOI: 10.1021/Ja9823870 |
0.663 |
|
| 1998 |
Nicolaou KC, Ohshima T, Hosokawa S, Van Delft FL, Vourloumis D, Xu JY, Pfefferkorn J, Kim S. Total synthesis of eleutherobin and eleuthosides A and B Journal of the American Chemical Society. 120: 8674-8680. DOI: 10.1021/Ja9810639 |
0.555 |
|
| 1998 |
Nicolaou KC, Kim S, Pfefferkorn J, Xu J, Ohshima T, Hosokawa S, Vourloumis D, Li T. Synthesis and biological activity of sarcodictyins Angewandte Chemie - International Edition. 37: 1418-1421. DOI: 10.1002/(SICI)1521-3773(19980605)37:10<1418::AID-ANIE1418>3.0.CO;2-5 |
0.436 |
|
| 1998 |
Nicolaou K, Kim S, Pfefferkorn J, Xu J, Ohshima T, Hosokawa S, Vourloumis D, Li T. Synthese und biologische Aktivität von Sarcodictyinen Angewandte Chemie. 110: 1484-1487. DOI: 10.1002/(Sici)1521-3757(19980518)110:10<1484::Aid-Ange1484>3.0.Co;2-P |
0.467 |
|
| 1997 |
Nicolau KC, Xu JY, Kim S, Ohshima T, Hosokawa S, Pfefferkorn J. Synthesis of the tricyclic core of eleutherobin and sarcodictyins and total synthesis of sarcodictyin A Journal of the American Chemical Society. 119: 11353-11354. DOI: 10.1021/Ja973000G |
0.368 |
|
| 1997 |
Nicolaou KC, van Delft F, Ohshima T, Vourloumis D, Xu J, Hosokawa S, Pfefferkorn J, Kim S, Li T. Total Synthesis of Eleutherobin Angewandte Chemie International Edition in English. 36: 2520-2524. DOI: 10.1002/Anie.199725201 |
0.479 |
|
| 1997 |
Nicolaou KC, Van Delft F, Ohshima T, Vourloumis D, Xu J, Hosokawa S, Pfefferkorn J, Kim S, Li T. Totalsynthese von Eleutherobin Angewandte Chemie. 109: 2630-2634. DOI: 10.1002/Ange.19971092239 |
0.332 |
|
| Show low-probability matches. |